Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,108.80
(
-0.36%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.96
(
4.38%
)
Bitcoin
78,014.25
(
-0.29%
)
News Focus
News Focus
Post# of 257441
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122884
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 247637

Thursday, 06/22/2023 4:20:55 PM

Thursday, June 22, 2023 4:20:55 PM

Post# of 257441
LLY/NVO/etc—EMA wants_more_info_on thyroid-cancer risk_of GLP-1 drugs:

https://www.fiercepharma.com/pharma/novo-nordisk-eli-lilly-face-scrutiny-eu-over-glp-1-drugs

The European Medicines Agency has flagged GLP-1 drugs, including Novo Nordisk's Ozempic and Wegovy, and Eli Lilly's Mounjaro, for a potential risk for thyroid cancer. The regulator is asking companies to submit more information by July 26.

Thyroid-cancer risk is a black-box warning in the FDA labels for these drugs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today